Profound Medical

Profound Medical Corp. is a medical technology company based in Mississauga, Canada, specializing in the development of innovative, incision-free therapeutic systems for image-guided ablation of diseased tissue. The company’s primary product, the TULSA-PRO system, integrates real-time magnetic resonance imaging (MRI) with robotically driven ultrasound technology to provide precise ablation of prostate tissue. Additionally, Profound Medical offers the Sonalleve platform, which targets uterine fibroids and bone metastases for palliative pain treatment. The company's solutions aim to address unmet medical needs by utilizing existing imaging infrastructure in hospitals and treatment facilities. Through a co-development agreement with GE Healthcare, Profound Medical is working to enhance accessibility to its TULSA-PRO system, ultimately striving to improve patient care and treatment outcomes across various medical conditions.